207 related articles for article (PubMed ID: 22319585)
1. Successful shortening of tuberculosis treatment using adjuvant host-directed therapy with FDA-approved phosphodiesterase inhibitors in the mouse model.
Maiga M; Agarwal N; Ammerman NC; Gupta R; Guo H; Maiga MC; Lun S; Bishai WR
PLoS One; 2012; 7(2):e30749. PubMed ID: 22319585
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant host-directed therapy with types 3 and 5 but not type 4 phosphodiesterase inhibitors shortens the duration of tuberculosis treatment.
Maiga M; Ammerman NC; Maiga MC; Tounkara A; Siddiqui S; Polis M; Murphy R; Bishai WR
J Infect Dis; 2013 Aug; 208(3):512-9. PubMed ID: 23641020
[TBL] [Abstract][Full Text] [Related]
3. Myeloid-Derived Suppressor Cells as Target of Phosphodiesterase-5 Inhibitors in Host-Directed Therapeutics for Tuberculosis.
Leukes V; Walzl G; du Plessis N
Front Immunol; 2020; 11():451. PubMed ID: 32269568
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of erectile dysfunction by phosphodiesterase-5 inhibitors and nonarteritic anterior ischemic optic neuropathy (NOIAN)].
Calvet C; Martin K; Robert G; Moore N; Eftekhari P; Farghal H; Molimard M; Ballanger P
Prog Urol; 2007 Sep; 17(5):920-7. PubMed ID: 17969789
[TBL] [Abstract][Full Text] [Related]
5. The use of sildenafil in the therapy of massive pulmonary embolism.
Dias-Junior CA
Intensive Care Med; 2006 Aug; 32(8):1284. PubMed ID: 16788805
[No Abstract] [Full Text] [Related]
6. Cardiovascular parameter changes in patients with erectile dysfunction using pde-5 inhibitors: a study with sildenafil and vardenafil.
Pomara G; Morelli G; Pomara S; Taddei S; Ghiadoni L; Dinelli N; Travaglini F; Dicuio M; Mondaini N; Salvetti A; Selli C
J Androl; 2004; 25(4):625-9. PubMed ID: 15223851
[TBL] [Abstract][Full Text] [Related]
7. Beyond pulmonary hypertension: sildenafil for chronic lung disease of prematurity.
Steinhorn RH; Kinsella JP; Abman SH
Am J Respir Cell Mol Biol; 2013 Feb; 48(2):iii-v. PubMed ID: 23378489
[No Abstract] [Full Text] [Related]
8. Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugs.
Clemens DL; Lee BY; Silva A; Dillon BJ; Masleša-Galić S; Nava S; Ding X; Ho CM; Horwitz MA
PLoS One; 2019; 14(5):e0215607. PubMed ID: 31075149
[TBL] [Abstract][Full Text] [Related]
9. The effects of quinapril and atorvastatin on the responsiveness to sildenafil in men with erectile dysfunction.
Bank AJ; Kelly AS; Kaiser DR; Crawford WW; Waxman B; Schow DA; Billups KL
Vasc Med; 2006 Nov; 11(4):251-7. PubMed ID: 17390549
[TBL] [Abstract][Full Text] [Related]
10. Sustained long-term benefit of sildenafil in primary pulmonary hypertension.
Sayin T; Ozenci M
Acta Cardiol; 2007 Feb; 62(1):47-9. PubMed ID: 17375892
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive Integrated Stress Response Inhibition Accelerates Tuberculosis Clearance in Mice.
Krug S; Prasad P; Xiao S; Lun S; Ruiz-Bedoya CA; Klunk M; Ordonez AA; Jain SK; Srikrishna G; Kramnik I; Bishai WR
mBio; 2023 Apr; 14(2):e0349622. PubMed ID: 36853048
[TBL] [Abstract][Full Text] [Related]
12. Statin adjunctive therapy shortens the duration of TB treatment in mice.
Dutta NK; Bruiners N; Pinn ML; Zimmerman MD; Prideaux B; Dartois V; Gennaro ML; Karakousis PC
J Antimicrob Chemother; 2016 Jun; 71(6):1570-7. PubMed ID: 26903278
[TBL] [Abstract][Full Text] [Related]
13. Nonpigmenting mucosal fixed drug eruption due to sildenafil citrate.
Ghosh SK; Bandyopadhyay D
J Sex Med; 2009 Dec; 6(12):3500-1. PubMed ID: 20092472
[No Abstract] [Full Text] [Related]
14. Clinical use of sildenafil in pulmonary artery hypertension.
Singh TP
Expert Rev Respir Med; 2010 Feb; 4(1):13-9. PubMed ID: 20387288
[TBL] [Abstract][Full Text] [Related]
15. Effects of sildenafil on nigrostriatal dopamine neurons in a murine model of Parkinson's disease.
Janis KL; Brennan RT; Drolet RE; Behrouz B; Kaufman SK; Lookingland KJ; Goudreau JL
J Alzheimers Dis; 2008 Sep; 15(1):97-107. PubMed ID: 18780970
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase 5 inhibitors in vascular systemic disorders.
Allanore Y
Joint Bone Spine; 2012 Jul; 79(4):338-40. PubMed ID: 22410367
[No Abstract] [Full Text] [Related]
17. Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension.
Montani D; Chaumais MC; Savale L; Natali D; Price LC; Jaïs X; Humbert M; Simonneau G; Sitbon O
Adv Ther; 2009 Sep; 26(9):813-25. PubMed ID: 19768639
[TBL] [Abstract][Full Text] [Related]
18. [A decade's evidence review of sildenafil citrate].
Zhang K; Zhu JC
Zhonghua Nan Ke Xue; 2009 Jan; 15(1):3-6. PubMed ID: 19288739
[TBL] [Abstract][Full Text] [Related]
19. Clinical potential of combined organic nitrate and phosphodiesterase type 5 inhibitor in treatment-resistant hypertension.
Oliver JJ; Hughes VE; Dear JW; Webb DJ
Hypertension; 2010 Jul; 56(1):62-7. PubMed ID: 20479335
[TBL] [Abstract][Full Text] [Related]
20. Sildenafil may improve sexual functioning in depressed women.
Harv Ment Health Lett; 2008 Oct; 25(4):7. PubMed ID: 19031587
[No Abstract] [Full Text] [Related]
[Next] [New Search]
